Literature DB >> 23228411

Assessing the impact of health technology assessment on the Austrian healthcare system.

Ines Schumacher1, Ingrid Zechmeister.   

Abstract

OBJECTIVES: In Austria, research in health technology assessment (HTA) has been conducted since the 1990s. The aim of this study is to analyze whether the HTA research program of the Institute of Technology Assessment (ITA) and the Ludwig Boltzmann Institute for HTA (LBI-HTA) have had an impact on the Austrian healthcare system.
METHODS: We applied qualitative and quantitative empirical research methods, such as interviewing, download analysis, questionnaire, retrospective routine data analysis, and media analysis. Data were analyzed according to a conceptual framework, considering seven impact categories (awareness, acceptance, process, decision, practice, final outcomes, enlightenment) and different target groups.
RESULTS: A rising number of downloads and single HTA reports with high media interest were identified. Interviews showed that HTA reports have increasingly been used for investment and reimbursement decisions, as well as for the preparation of negotiations. Economic impact was indicated by decreased expenditures due to HTA recommendations. Overall, knowledge about evidence-based medicine increased and, in places, an "HTA culture" can be recognized. Yet, several decision-making processes occur at all levels without the use of HTA.
CONCLUSIONS: The analysis demonstrated an impact within all predefined categories; however, it depends on the system level and its target groups. HTA reports are primarily used by hospital management, (social) insurances, and the Austrian Ministry of Health. Nevertheless, there is still potential to increase the impact of HTA. Therefore, the inclusion of HTA in decision-making processes in Austria needs to move from a voluntary basis to a mandatory one.

Mesh:

Year:  2012        PMID: 23228411     DOI: 10.1017/S0266462312000748

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  6 in total

Review 1.  Effects and repercussions of local/hospital-based health technology assessment (HTA): a systematic review.

Authors:  Marie-Pierre Gagnon; Marie Desmartis; Thomas Poder; William Witteman
Journal:  Syst Rev       Date:  2014-10-28

Review 2.  Sustainability in Health care by Allocating Resources Effectively (SHARE) 2: identifying opportunities for disinvestment in a local healthcare setting.

Authors:  Claire Harris; Kelly Allen; Richard King; Wayne Ramsey; Cate Kelly; Malar Thiagarajan
Journal:  BMC Health Serv Res       Date:  2017-05-05       Impact factor: 2.655

3.  Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact.

Authors:  Robyn Millar; Alec Morton; Maria Vittoria Bufali; Sven Engels; Saudamini Vishwanath Dabak; Wanrudee Isaranuwatchai; Kalipso Chalkidou; Yot Teerawattananon
Journal:  Cost Eff Resour Alloc       Date:  2021-07-02

4.  Development, implementation and evaluation of an evidence-based program for introduction of new health technologies and clinical practices in a local healthcare setting.

Authors:  Claire Harris; Marie Garrubba; Kelly Allen; Richard King; Cate Kelly; Malar Thiagarajan; Beverley Castleman; Wayne Ramsey; Dina Farjou
Journal:  BMC Health Serv Res       Date:  2015-12-28       Impact factor: 2.655

5.  Sustainability in Health care by Allocating Resources Effectively (SHARE) 9: conceptualising disinvestment in the local healthcare setting.

Authors:  Claire Harris; Sally Green; Wayne Ramsey; Kelly Allen; Richard King
Journal:  BMC Health Serv Res       Date:  2017-09-08       Impact factor: 2.655

6.  Sustainability in Health care by Allocating Resources Effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation.

Authors:  Claire Harris; Sally Green; Adam G Elshaug
Journal:  BMC Health Serv Res       Date:  2017-09-08       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.